One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy.

Michele Francesco ChiappettaAnna ViolaMauro MastronardiLaura TurchiniSonia CarparelliAdele OrlandoGiuseppe BiscagliaAgnese MirandaLaura GuidaGiuseppe CostantinoFranco ScaldaferriFabrizio BossaSara RennaMaria CappelloAngela AlibrandiAmbrogio OrlandoAlessandro ArmuzziWalter Fries

Published in: Expert opinion on biological therapy (2021)

Data from our real-life cohort of refractory UC patients suggest satisfactory effectiveness and a good safety of ustekinumab.

Keyphrases

end stage renal disease
ulcerative colitis
newly diagnosed
ejection fraction
chronic kidney disease
randomized controlled trial
systematic review
peritoneal dialysis
prognostic factors
big data
cross sectional